CORAH SENIK: Open Payments
NPI 1417156134 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 58 payments from 14 companies in 2025. Trend: 2023 $632 · 2024 $653 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $160 |
| GENZYME CORPORATION | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 7 | $114 |
| ABBVIE INC. | 5 | $99 |
| Organon LLC | 13 | $95 |
| Amgen Inc. | 4 | $63 |
| UCB, Inc. | 3 | $54 |
| Botanix SB Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: DUPIXENT, COSENTYX, ILUMYA, SKYRIZI, VTAMA, OTEZLA, Winlevi, Bimzelx.
Industry payments across MI — which companies pay providers there.
